Abstract:Objective. The genuine causal nexus between mitochondrial function‐related proteins and diabetic nephropathy remains enigmatic and arduous to delineate conclusively. In this study, we employed a bidirectional two‐sample Mendelian randomization analysis, a robust approach, to scrutinize and discern the causal interplay between them. Methods. In this investigation, the datasets pertaining to diabetic nephropathy and mitochondrial function‐related proteins were meticulously extracted from the comprehensive IEU OpenGWAS Project database. The principal analytical method employed was the inverse variance weighted approach. In addition, MR‐Egger regression, simple median, and weighted median methodologies were utilized as supplementary tools to interrogate the causal associations of mitochondrial function‐related proteins with the risk of diabetic nephropathy. Semsitivity analyses were conducted using the Cochran's Q test and MR‐Egger regression intercept. The significance level, as indicated by the P value, was employed as the pivotal metric for interpreting the findings. Result. A total of 90 single nucleotide polymorphisms associated with mitochondrial function‐related proteins were meticulously screened as instrumental variables. The inverse variance weighted analysis unveiled a positive causal nexus between mitochondrial glutamate carrier 2, 2,4‐dienoyl‐CoA reductase mitochondrial levels, 39S ribosomal protein L52 mitochondrial, ATP synthase subunit beta mitochondrial, Serine‐‐tRNA ligase mitochondrial, itochondrial sodium/hydrogen exchanger 9B2, and Esseential MCU regulator mitochondrial, and diabetic nephropathy. Conversely, pyruvate dehydrogenase (acetyl‐transferring) kinase isozyme 1 mitochondrial exhibited a negative causal relationship with diabetic nephropathy., the MR‐Egger intercept test yielded non‐multiplicative results (P > 0.05), affirming the robustness and validity of Mendelian randomization as an effective method for causal inference in this investigation. Furthermore, the reverse Mendelian randomization analysis failed to demonstrate any causal link between diabetic nephropathy and an augmented risk associated with positively identified mitochondrial function‐related proteins. Conclusion. Pyruvate dehydrogenase (acetyl‐transferring) kinase isozyme 1 mitochondrial stands out as an independent protective factor against diabetic nephropathy. The findings bear significant clinical implications, offering pivotal insights into the development of targeted preventive and therapeutic interventions, tailored specifically for combating diabetic nephropathy.

Identification of potential drug targets for diabetic polyneuropathy through Mendelian randomization analysis

Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes

Therapeutic targets for diabetic kidney disease: proteome-wide Mendelian randomization and colocalization analyses

Potential disease biomarkers for diabetic retinopathy identified through Mendelian randomization analysis

Investigating the relationship between blood metabolites and diabetic retinopathy using two-sample mendelian randomization and in vivo validation

Exploring causal correlations between plasma proteins and peripheral neuropathy: a Mendelian randomization

The causal role between circulating immune cells and diabetic nephropathy: a bidirectional Mendelian randomization with mediating insights

Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy

Elucidating the Role of Genetically Determined Metabolites in Diabetic Retinopathy: Insights from a Mendelian Randomization Analysis

Novel Protein Biomarkers and Therapeutic Targets for Type 1 Diabetes and Its Complications: Insights from Summary-Data-Based Mendelian Randomization and Colocalization Analysis

Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening

Causal role of immune cells in diabetic nephropathy: a bidirectional Mendelian randomization study

Mendelian randomization based on immune cells in diabetic nephropathy

Genetic Association between Lipid-Regulating Drug Targets and Diabetic Retinopathy: A Drug Target Mendelian Randomization Study

Relationship between circulating metabolites and diabetic retinopathy: a two-sample Mendelian randomization analysis

Causality between diabetes and membranous nephropathy: Mendelian randomization

Transcriptome analysis combined with Mendelian randomization screening for biomarkers causally associated with diabetic retinopathy

Identification and validation of NAD+ metabolism-related biomarkers in patients with diabetic peripheral neuropathy

Unveiling potential therapeutic targets for diabetes-induced frozen shoulder through Mendelian randomization analysis of the human plasma proteome

Integrating Mendelian randomization and single-cell RNA sequencing to identify therapeutic targets of baicalin for type 2 diabetes mellitus

Bidirectional Two‐Sample Mendelian Randomization Analysis Unveils a Causal Correlation of Mitochondrial Function‐Related Proteins with the Risk of Diabetic Nephropathy